Clinical relevance of differential lymphocyte recovery after alemtuzumab therapy for multiple sclerosis. Cossburn MD, Harding K, Ingram G, El-Shanawany T, Heaps A, Pickersgill TP, Jolles S, Robertson NP Neurology. 2013 Jan 1; 80(1):55-61. Epub 2012 Dec 12. PMID: 23243077. Abstract CommentRecommendBookmarkWatch